CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death
2021 · iScience · 149 citations
https://doi.org/10.1016/j.isci.2021.102711
E
Emile Foucat
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
2.1K
Citations
12
h-index
14
i10-index
Emile Foucat is an academic researcher from Inserm. The author has contributed to research in topics: COVID-19 Clinical Research Studies & HIV Research and Treatment & Immunotherapy and Immune Responses. The author has an h-index of 12, co-authored 21 publications.
ORCID: 0000-0003-1351-7159Papers by this author
worksAdult-onset type 1 diabetes patients display decreased IGRP-specific Tr1 cells in blood
2015 · Clinical Immunology · 26 citations
https://doi.org/10.1016/j.clim.2015.08.014
Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases
2024 · Nature Communications · 13 citations
https://doi.org/10.1038/s41467-024-51453-z
CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death
2022 · iScience · 3 citations
https://doi.org/10.1016/j.isci.2022.105715
Innate and Cellular Immune Response to the Ebola Vaccine Ad26.ZEBOV, MVA-BN-Filo: An Ancillary Study of the EBL2001 Phase 2 Trial
2024 · The Journal of Infectious Diseases · 1 citations
https://doi.org/10.1093/infdis/jiae360
Characterization and comparison of immunity against MPXV for individuals infected with MPXV or vaccinated with modified vaccinia Ankara vaccines
2025 · The Journal of Immunology · 1 citations
https://doi.org/10.1093/jimmun/vkae031
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat